Meghna P Mansukhani1, Bhanu Prakash Kolla1,2, Zhen Wang3, Timothy I Morgenthaler1,4. 1. Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota. 2. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota. 3. Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota. 4. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
STUDY OBJECTIVES: Various criteria have been used for scoring hypopneas, leading to difficulties when comparing results in clinical and research settings. We conducted a systematic review and meta-analysis to assess the effect of different hypopnea definitions on the diagnosis, severity, and clinical implications of sleep-disordered breathing (SDB). METHODS: Ovid MEDLINE, Embase, and Scopus databases were queried for English-language publications from inception through March 7, 2017. Studies that directly compared various hypopnea definitions were eligible. The hierarchical summary receiver operating characteristic model was used to jointly estimate diagnostic performance for comparisons between criteria. RESULTS: The initial search yielded 2,828 abstracts; 28 met inclusion criteria. After reviewing reference lists and expert review, five additional articles were identified. Most of the studies were cross-sectional or retrospective in nature. Eleven studies compared 2007 recommended criteria with 2012 criteria; 6 of these (evaluating 6,628 patients) were suitable for inclusion in the meta-analysis. Using the 2012 definition (≥ 3% desaturation or arousal) as the reference standard, the 2007 definition (≥ 4% desaturation) showed a sensitivity of 82.7% (95% confidence interval 0.72-0.90) and specificity of 93.2% (95% confidence interval 0.82-0.98). Although 2007 criteria were found to be associated with prevalent cardiovascular (CV) disease and increased risk of CV death, the 2012 criteria appeared to correspond better with intermediate CV risk markers based on two abstracts. CONCLUSIONS: As expected, 2012 hypopnea scoring criteria resulted in a greater prevalence and severity of SDB. Data regarding the effect of varying hypopnea definitions on clinical outcomes, quality of life, health care costs, and mortality rates are limited. COMMENTARY: A commentary on this article appears in this issue on page 683.
STUDY OBJECTIVES: Various criteria have been used for scoring hypopneas, leading to difficulties when comparing results in clinical and research settings. We conducted a systematic review and meta-analysis to assess the effect of different hypopnea definitions on the diagnosis, severity, and clinical implications of sleep-disordered breathing (SDB). METHODS: Ovid MEDLINE, Embase, and Scopus databases were queried for English-language publications from inception through March 7, 2017. Studies that directly compared various hypopnea definitions were eligible. The hierarchical summary receiver operating characteristic model was used to jointly estimate diagnostic performance for comparisons between criteria. RESULTS: The initial search yielded 2,828 abstracts; 28 met inclusion criteria. After reviewing reference lists and expert review, five additional articles were identified. Most of the studies were cross-sectional or retrospective in nature. Eleven studies compared 2007 recommended criteria with 2012 criteria; 6 of these (evaluating 6,628 patients) were suitable for inclusion in the meta-analysis. Using the 2012 definition (≥ 3% desaturation or arousal) as the reference standard, the 2007 definition (≥ 4% desaturation) showed a sensitivity of 82.7% (95% confidence interval 0.72-0.90) and specificity of 93.2% (95% confidence interval 0.82-0.98). Although 2007 criteria were found to be associated with prevalent cardiovascular (CV) disease and increased risk of CV death, the 2012 criteria appeared to correspond better with intermediate CV risk markers based on two abstracts. CONCLUSIONS: As expected, 2012 hypopnea scoring criteria resulted in a greater prevalence and severity of SDB. Data regarding the effect of varying hypopnea definitions on clinical outcomes, quality of life, health care costs, and mortality rates are limited. COMMENTARY: A commentary on this article appears in this issue on page 683.
Authors: Stuart F Quan; Michael E Griswold; Conrad Iber; F Javier Nieto; David M Rapoport; Susan Redline; Mark Sanders; Terry Young Journal: Sleep Date: 2002-12 Impact factor: 5.849
Authors: S Redline; V K Kapur; M H Sanders; S F Quan; D J Gottlieb; D M Rapoport; W H Bonekat; P L Smith; J P Kiley; C Iber Journal: Am J Respir Crit Care Med Date: 2000-02 Impact factor: 21.405
Authors: Rohit Budhiraja; Sogol Javaheri; Sairam Parthasarathy; Richard B Berry; Stuart F Quan Journal: J Clin Sleep Med Date: 2020-10-15 Impact factor: 4.062
Authors: Risa Nakase-Richardson; Marie N Dahdah; Emily Almeida; Peter Ricketti; Marc A Silva; Karel Calero; Ulysses Magalang; Daniel J Schwartz Journal: J Clin Sleep Med Date: 2020-06-15 Impact factor: 4.062
Authors: Kara L Dupuy-McCauley; Harsha V Mudrakola; Brendon Colaco; Vichaya Arunthari; Katarzyna A Slota; Timothy I Morgenthaler Journal: J Clin Sleep Med Date: 2021-06-01 Impact factor: 4.324
Authors: J Daryl Thornton; Katherine A Dudley; Gul Jana Saeed; Sheeja T Schuster; Amy Schell; James C Spilsbury; Sanjay R Patel Journal: Ann Am Thorac Soc Date: 2022-02